45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,498
Insurances with rates
17
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 12203919 | TREMELIMUMAB ACTL 300 MG 15 ML VIAL | $140,838 | $70,419 | — | — | 1 |
| 12203919 | TREMELIMUMAB ACTL 300 MG 15 ML VIAL | $140,838 | $70,419 | — | — | 8 |
| 12203919 | TREMELIMUMAB ACTL 300 MG 15 ML VIAL | $140,838 | $70,419 | — | — | 10 |
| 12203335 | IPILIMUMAB 200 MG 40 ML VIAL | $123,597 | $61,798 | — | — | 1 |
| 12203335 | IPILIMUMAB 200 MG 40 ML VIAL | $123,597 | $61,798 | — | — | 8 |
| 12203335 | IPILIMUMAB 200 MG 40 ML VIAL | $123,597 | $61,798 | — | — | 10 |
| 12203385 | ALEMTUZUMAB 12 MG 1.2 ML VIAL | $101,502 | $50,751 | — | — | 1 |
| 12203385 | ALEMTUZUMAB 12 MG 1.2 ML VIAL | $101,502 | $50,751 | — | — | 8 |
| 12203385 | ALEMTUZUMAB 12 MG 1.2 ML VIAL | $101,502 | $50,751 | — | — | 10 |
| 12203493 | USTEKINUMAB 90 MG ML SYRINGE | $99,479 | $49,740 | — | — | 1 |
| 12203493 | USTEKINUMAB 90 MG ML SYRINGE | $99,479 | $49,740 | — | — | 8 |
| 12203493 | USTEKINUMAB 90 MG ML SYRINGE | $99,479 | $49,740 | — | — | 10 |
| 12203784 | RAVULIZUMAB CWVZ 1100 MG 11 ML VIAL | $83,776 | $41,888 | — | — | 1 |
| 12203784 | RAVULIZUMAB CWVZ 1100 MG 11 ML VIAL | $83,776 | $41,888 | — | — | 8 |
| 12203784 | RAVULIZUMAB CWVZ 1100 MG 11 ML VIAL | $83,776 | $41,888 | — | — | 10 |
| 12203300 | CABAZITAXEL 60 MG 6 ML VIAL | $49,137 | $24,569 | — | — | 1 |
| 12203300 | CABAZITAXEL 60 MG 6 ML VIAL | $49,137 | $24,569 | — | — | 8 |
| 12203300 | CABAZITAXEL 60 MG 6 ML VIAL | $49,137 | $24,569 | — | — | 10 |
| 12203410 | BRENTUXIMAB VEDOTIN 50 MG VIAL | $44,943 | $22,472 | — | — | 1 |
| 12203410 | BRENTUXIMAB VEDOTIN 50 MG VIAL | $44,943 | $22,472 | — | — | 8 |
| 12203410 | BRENTUXIMAB VEDOTIN 50 MG VIAL | $44,943 | $22,472 | — | — | 10 |
| 12203490 | LEUPROLIDE ACETATE LUPRON 45 MG KIT | $43,946 | $21,973 | — | — | 1 |
| 12203490 | LEUPROLIDE ACETATE LUPRON 45 MG KIT | $43,946 | $21,973 | — | — | 8 |
| 12203490 | LEUPROLIDE ACETATE LUPRON 45 MG KIT | $43,946 | $21,973 | — | — | 10 |
| 12203767 | LUSPATERCEPT AAMT 75 MG 1.5 ML VIAL | $41,603 | $20,801 | — | — | 1 |
| 12203767 | LUSPATERCEPT AAMT 75 MG 1.5 ML VIAL | $41,603 | $20,801 | — | — | 8 |
| 12203767 | LUSPATERCEPT AAMT 75 MG 1.5 ML VIAL | $41,603 | $20,801 | — | — | 10 |
| 12203599 | ATEZOLIZUMAB 1200 MG 20 ML VIAL | $40,246 | $20,123 | — | — | 1 |
| 12203599 | ATEZOLIZUMAB 1200 MG 20 ML VIAL | $40,246 | $20,123 | — | — | 8 |
| 12203599 | ATEZOLIZUMAB 1200 MG 20 ML VIAL | $40,246 | $20,123 | — | — | 10 |
| 12203882 | DARATUMUMAB HYALURONIDASE FIHJ 1800 MG 30000 UNITS | $35,465 | $17,733 | — | — | 1 |
| 12203882 | DARATUMUMAB HYALURONIDASE FIHJ 1800 MG 30000 UNITS | $35,465 | $17,733 | — | — | 8 |
| 12203882 | DARATUMUMAB HYALURONIDASE FIHJ 1800 MG 30000 UNITS | $35,465 | $17,733 | — | — | 10 |
| 12203253 | VEDOLIZUMAB 300 MG 5 ML VIAL | $31,557 | $15,779 | — | — | 1 |
| 12203253 | VEDOLIZUMAB 300 MG 5 ML VIAL | $31,557 | $15,779 | — | — | 8 |
| 12203253 | VEDOLIZUMAB 300 MG 5 ML VIAL | $31,557 | $15,779 | — | — | 10 |
| 12203850 | CEMIPLIMAB RWLC 350 MG 7 ML VIAL | $31,438 | $15,719 | — | — | 1 |
| 12203850 | CEMIPLIMAB RWLC 350 MG 7 ML VIAL | $31,438 | $15,719 | — | — | 8 |
| 12203850 | CEMIPLIMAB RWLC 350 MG 7 ML VIAL | $31,438 | $15,719 | — | — | 10 |
| 12203336 | IPILIMUMAB 50 MG 10 ML VIAL | $30,899 | $15,450 | — | — | 1 |
| 12203336 | IPILIMUMAB 50 MG 10 ML VIAL | $30,899 | $15,450 | — | — | 8 |
| 12203336 | IPILIMUMAB 50 MG 10 ML VIAL | $30,899 | $15,450 | — | — | 10 |
| 12203456 | LEUPROLIDE ACETATE LUPRON 30 MG KIT | $29,297 | $14,649 | — | — | 1 |
| 12203456 | LEUPROLIDE ACETATE LUPRON 30 MG KIT | $29,297 | $14,649 | — | — | 8 |
| 12203456 | LEUPROLIDE ACETATE LUPRON 30 MG KIT | $29,297 | $14,649 | — | — | 10 |
| 12203724 | ATEZOLIZUMAB 840 MG 14 ML VIAL | $28,172 | $14,086 | — | — | 1 |
| 12203724 | ATEZOLIZUMAB 840 MG 14 ML VIAL | $28,172 | $14,086 | — | — | 8 |
| 12203724 | ATEZOLIZUMAB 840 MG 14 ML VIAL | $28,172 | $14,086 | — | — | 10 |
| 12203547 | NIVOLUMAB 240 MG 24 ML VIAL | $26,781 | $13,390 | — | — | 1 |
| 12203547 | NIVOLUMAB 240 MG 24 ML VIAL | $26,781 | $13,390 | — | — | 8 |
Showing top 50 of 12,498 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.